Connect with us

Health

New COVID-19 vaccination appointments available for Ottawa residents 70 and older – CTV Edmonton

Published

 on


OTTAWA —
The city of Ottawa is opening up more appointment slots for residents aged 70 and older to receive the COVID-19 vaccine.

In a statement Friday morning, the city said it has confirmed delivery of additional doses of the COVID-19 vaccine and is able to offer more vaccination appointments to eligible residents.

Individuals born in or before 1951 can now book appointments at the city of Ottawa’s community clinics between April 8 and 21.

Last Monday, Ontario expanded the eligibility to receive the COVID-19 vaccine to residents aged 70 and over in the city of Ottawa. Within hours, all appointments until April 7 were booked in Ottawa.

The city says appointments will be available at the four community vaccination clinics:

  • Nepean Sportsplex
  • Ruddy Family YMCA-YWCA
  • Eva James Memorial Community Centre
  • Ottawa City Hall

When you book an appointment through the provincial booking system, you will receive a confirmation code. Bring the code with you when you go to your appointment.

To book an appointment, you can visit Ontario’s online booking system or call the provincial vaccine booking line at 1-833-943-3900 between 8 a.m. and 8 p.m., seven days a week.

What you need to book an appointment for a COVID-19 vaccine

The Ontario government says when booking an appointment, you will be asked for the following information:

  • Government of Ontario green photo health card
  • Birth date
  • Postal code
  • Email address or phone number

At the time of booking, eligible individuals will schedule their first and second vaccination appointments

Let’s block ads! (Why?)



Source link

Continue Reading

Health

COVID cases in Ontario could spike to 30,000 per day by June

Published

 on

TORONTO (Reuters) – New cases of COVID-19 in Canada‘s most populous province could rise more than six fold, topping 30,000 per day by early June if public health measures are weak and vaccination rates remain flat, a panel of experts advising the province of Ontario said on Friday.

Even if measures to control the virus are “moderate,” the number of patients in Ontario ICUs could reach 2,000 in May, up from 695 on Friday.

The College of Physicians and Surgeons of Ontario told doctors last week they may soon have to decide who can and cannot receive intensive care.

 

(Reporting by Allison Martell; Editing by Chris Reese)

Continue Reading

Health

Moderna sees shortfall in Britain COVID vaccine shipments, EU deliveries on track

Published

 on

ZURICH (Reuters) – U.S. drugmaker Moderna expects a shortfall in COVID-19 vaccine doses from its European supply chain hitting second-quarter delivery quantities for Britain and Canada, though European Union– and Swiss-bound shipments are on track, a spokesperson said.

The delays, first announced on Friday when Canada said Moderna would be delivering only about half the planned 1.2 million doses by the end of April, come as Switzerland’s Lonza ramps up three new production lines to make active ingredients for Moderna vaccine supplies outside of the United States.

“The trajectory of vaccine manufacturing ramp-up is not linear, and despite best efforts, there is a shortfall in previously estimated doses from the European supply chain,” Moderna said in a statement.

Lonza didn’t immediately return a phone call and email seeking comment on any issues in its production.

 

(Reporting by John Miller; editing by David Evans)

Continue Reading

Health

Moderna says vaccines to Canada to be delayed due to Europe shortfall

Published

 on

(Reuters) -Moderna Inc said on Friday a shortfall in COVID-19 vaccine doses from its European supply chain will lead to a delay in deliveries to some countries including Canada.

The drugmaker would be delivering only 650,000 doses by April end as opposed to 1.2 million, Canada‘s Procurement Minister Anita Anand said in a statement.

She said one to two million doses of the 12.3 million doses scheduled for delivery by Moderna in the second quarter would be delayed until the third.

Moderna officials in Europe did not immediately comment on the reason for the delays or give the total number of countries that would be impacted.

“Vaccine manufacturing is a highly complex process and a number of elements, including human and material resources have factored into this volatility,” said Patricia Gauthier, an executive at Moderna Canada.

Canada has distributed a total of 2.82 million doses of the Moderna vaccine as of April 14 and 12.7 million doses of COVID-19 vaccines in total.

Moderna has been aiming to deliver 700 million to 1 billion doses of the COVID-19 globally this year, including from plants in Europe and the United States.

Swiss contract drug manufacturer Lonza makes active ingredients for Moderna’s vaccine in Visp, but it was still ramping up three new production lines that once operational would be able to produce 300 million shots annually.

The current supply, demand and distribution landscape has led the drugmaker to make adjustments in the expected second-quarter deliveries, Gauthier said.

(Reporting by Manas Mishra in Bengaluru, Allison Martell in Toronto and John Miller in Zurich; Editing by Arun Koyyur)

Continue Reading

Trending